From cancer platforms to autoimmune and cardiovascular disease Much of the clinical trial expansion in cell and gene therapies can be attributed to chimeric antigen receptor T-cell therapies, which were historically designed for cancer care
Wegovy is a once-weekly subcutaneous injection that can be given at any time of day, with or without food, so the two medications can be easily coordinated without timing conflicts
Upon stimulation by cytokines such as Tumor Necrosis Factor-alpha (TNF-) or Interleukin-1 (IL-1), endothelial cells undergo significant changes, including the de novo synthesis and cell surface expression of adhesion molecules like E-selectin, ICAM-1, and VCAM-1 [1] [2]
The people who achieve the best GLP-1 before and after transformations are almost universally the ones who prioritize protein from the very beginning
HUBERMAN: And then at least according to my eight sleep sleep tracker or my whoop sleep tracker, I wasn't getting nearly as much rapid eye movement sleep as I normally would
Industry research also shows that demand for GLP-1 programs is exploding in 2025